Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,425,517 papers from all fields of science
Search
Sign In
Create Free Account
CD33 antigen
Known as:
CD33
, gp67, Glycoprotein
, Sialic Acid Binding Ig like Lectin 3
Expand
A 67-kDa sialic acid binding lectin that is specific for MYELOID CELLS and MONOCYTE-MACROPHAGE PRECURSOR CELLS. This protein is the smallest siglec…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Broader (1)
CD Antigens
CD33 Ag:PrThr:Pt:Tiss:Ord:Immune stain
CD33 Expressing Cell Count
CD33 gene
CD33 wt Allele
Expand
Narrower (1)
CD33 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Autologous T Cells Modified to Co-Express CD33-Specific Chimeric Antigen Receptor and a Kill Switch for Treatment of CD33+ Acute Myeloid Leukemia
Degang Song
,
M. Swartz
,
+6 authors
T. Chan
2017
Corpus ID: 80268138
Relapsed/refractory acute myeloid leukemia (AML) is an aggressive malignancy with poor outcomes underscoring the need to…
Expand
2016
2016
Abstract 3123: Aberrant expression of CD33 is associated with poor prognosis in patients with multiple myeloma and tumor progression
Ki Hong Lee
,
H. Seo
,
+4 authors
S. Kong
2016
Corpus ID: 78368338
Background: Aberrant antigen expressions of plasma cells in patients with multiple myeloma (MM) have used for diagnosis and…
Expand
2016
2016
A Xenograft Model of Lymphocyte-Independent, Effector-Driven Macrophage Activation SyndRome Amenable to Anti-CD33 and Anti-IL-6R Treatment
M. Wunderlich
,
C. Stockman
,
+5 authors
J. Mulloy
2016
Corpus ID: 79615002
Macrophage Activation Syndrome (MAS) is a form of secondary hemophagocytic lymphohistiocytosis (HLH) that frequently complicates…
Expand
2013
2013
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by…
C. Friesen
,
M. Roscher
,
+4 authors
E. Miltner
European Journal of Cancer
2013
Corpus ID: 26626142
2010
2010
BCR/ABL+ CML Stem Cells (CD34+/CD38-) Express High Levels of CD33 and Are Responsive to a CD33-Targeting Drug: a New Potential Concept for Eradication of CML Stem Cells.
H. Herrmann
,
S. Cerny‐Reiterer
,
+9 authors
P. Valent
2010
Corpus ID: 208436813
Abstract 3382 Siglec-3 (CD33) is an established therapeutic target in acute myeloid leukemia (AML). We and others have shown…
Expand
2004
2004
Improved PC1/3 production through recombinant expression in insect cells and larvae.
N. Rabah
,
D. Gauthier
,
D. Gauthier
,
C. Lazure
Protein Expression and Purification
2004
Corpus ID: 10702444
2004
2004
Expression of CD33-related Siglecs on human eosinophils, basophils and mast cells
E. Nutku
,
H. Aizawa
,
+4 authors
B. Bochner
2004
Corpus ID: 72720023
2001
2001
A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Sylvie Freeman
,
Helen Birrell
,
Karla J. D’Alessio
,
Connie L. Erickson-Miller
,
Kristine Kay Kikly
,
Patrick Camilleri
European Journal of Biochemistry
2001
Corpus ID: 25909347
The siglecs (sialic acid-binding immunoglobulin-like lectins) mediate sialic acid-dependent cellular interactions and may in some…
Expand
2000
2000
CD33: Siglec-3, gp67
C. Isacke
2000
Corpus ID: 90372791
1996
1996
A functional analysis of CD33 and CD34
E. K. Barber
1996
Corpus ID: 82712608
In the bone marrow, CD34 is the best currently available marker of human multipotential stem cells and is downregulated upon the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE